Impedimed Share Price and Company Fundamentals
Last traded: Today at 2:36 AM
ImpediMed Limited, a medical technology company, develops, manufactures and sells bioimpedance spectroscopy (BIS) technology medical devices and software services in Australia, Europe, the United States, and internationally. The company offers SOZO, a noninvasive BIS device for the clinical assessment of lymphedema, which uses bioimpedance measurements to assess fluid levels and tissue composition; L-Dex analysis for lymphedema; BodyComp Analysis, a point-of-care body composition analysis; and HF-Dex analysis for point-of-care heart failure fluid assessment. It also provides SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. ImpediMed Limited was incorporated in 1999 and is headquartered in Carlsbad, California with additional office in Lindfield, Australia.
Key Metrics
PE ratio
-
PB ratio
2.10
Dividend yield
-
Beta
1.42
Market cap
$42.81M
Enterprise value
$34.94M
Company profile
| Industry / Sector | Medical Devices / Healthcare |
|---|---|
| Full time employees | 77 |
| Website | https://www.impedimed.com |
| Mailing address | 5900 Pasteur Court Suite 125 Carlsbad CA 92008 United States |
| Phone / Fax | 760 585 2100 / |
Dividends
More: Impedimed Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Impedimed paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.IPD dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Impedimed.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Dr. Parmjot Bains M.D. | MD, CEO & Director | ||
| Mr. McGregor Grant BEc, C.A., FCIS, GAICD | CFO & Executive Director | ||
| Mr. Dennis Schlaht | Senior Vice President of R&D and Technology | ||
| Mr. Michael John Bassett | VP of Business Development & Investor Relations | ||
| Mr. Scott Long | Senior Vice President of US Sales, Key Accounts, & Renewals | ||
| Ms. Julie Kuhlken | Senior Director of Marketing | ||
| Ms. Ashley Munoz | Director of Human Resources | ||
| Dr. Steven Chen M.B.A., M.D. | Chief Medical Officer | ||
| Ms. Leanne Ralph AAICD, ACIS, BBus | Company Secretary |
Profitability and management effectiveness
Profit margin
-182.62%
Operating margin
-170.15%
Return on assets
-32.44%
Return on equity
-75.89%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Impedimed is 42.81M and its enterprise value is 34.94M. The enterprise value to revenue ratio of IPD is 2.75. The enterprise value to EBITDA ratio of IPD is -1.53.
The IPD's stocks Beta value is 1.42 making it 42% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Impedimed (IPD)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Polynovo (PNV)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Impedimed (ASX:IPD) Frequently Asked Questions
1. What is Impedimed's Stock Symbol?
Impedimed trades on ASX under the ticker symbol "IPD".
2. What is Impedimed's stock price today?
One share of IPD stock can currently be purchased for approximately $0.021.
3. How can I contact Impedimed?
Impedimed's mailing address is 5900 Pasteur Court Suite 125 Carlsbad CA 92008 United States. The company can be reached via phone at 760 585 2100.
4. What is Impedimed's official website?
The official website of Impedimed is https://www.impedimed.com.